BRIEF-Lilly, Astrazeneca to develop potentially disease-modifying Alzheimer's treatment

* Lilly and Astrazeneca to develop second potentially disease-modifying treatment for Alzheimer's disease
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.